#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis II Bronchopulmonary dysplasia Malignant central nervous system neoplasm Retinopathy proliferative Corneal neovascularisation Systemic mastocytosis Chondrodystrophy Acute on chronic liver failure Cutaneous lupus erythematosus Neurodegenerative disorder Thrombotic thrombocytopenic purpura Autoimmune disorder Autoimmune hepatitis Heart disease congenital Liposarcoma recurrent More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Diagnostics Mantle cell lymphoma stage II – Basic Information Castleman’s disease Splenic marginal zone lymphoma – Trials in Disease Aicardi-Goutieres syndrome Turner’s syndrome – Diagnostics Basal cell naevus syndrome – Life with Disease Vascular malformation – Diagnostics Gaucher’s disease type III – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    A/H1N1 INFLUENZA VACCINE Sulodexide Candesartan Cilexetil Ranolazine OMTX705 Bendamustine Tamibarotene Dog Epithelium Extract Fianlimab Fluticasone Propionate Prilocaine Hydralazine Hydrochloride Irbesartan Nemolizumab 20-HYDROXYECDYSONE Elamipretide Trihydrochloride Pazopanib A24110He Larotrectinib Sulfate Clobetasol More therapies…

    Learn about Your Condition

    Cutaneous T-cell lymphoma Peripheral artery angioplasty Polymyalgia rheumatica Albuminuria Dengue fever Alexander disease Erythema migrans Metastatic neoplasm Plasma cell leukaemia Toxicity to various agents Hypersomnia Chronic sinusitis Premature rupture of membranes HER2 positive breast cancer Bile acid synthesis disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Osteoarthritis
    • Overweight
    Bulgaria Denmark Greece Italy Poland Spain

  • A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Czechia France Germany Greece +4

  • A study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ublituximab
    Poland

  • A study to evaluate the safety and effectiveness of surlorian in adults with RYR1-related myopathy

    Recruiting

    2 1
    Investigated Diseases:
    • Congenital myopathy
    France Germany The Netherlands Spain

  • A study to evaluate the safety and effectiveness of ANXV in patients with diabetic retinopathy or retinal vein occlusion

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic retinopathy
    • Retinal vein occlusion
    Investigated Drugs:
    • ANXV
    Germany

  • A study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Zasocitinib
    Germany Italy Poland Spain
Previous Page
1 … 33 34 35 36 37 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!